BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2007
View Archived Issues
Novel anticancer drugs disclosed in recent patent literature
Read More
Updated findings for Genentech oncology candidates
Read More
Phase II study shows tipifarnib is active in relapsed/refractory acute myeloid leukemia
Read More
Novel formalin-inactivated vaccine protects against Ross River virus infection in preclinical tests
Read More
Purinergic P2X3/P2X2/3 receptor blockade attenuates cold and mechanical allodynia in rat pain models
Read More
Interim analysis planned for BiovaxID phase III trial
Read More
Biovitrum's novel tyrosine kinase inhibitor shows preclinical activity against AML
Read More
Recent patents describe new treatment options for cardiovascular diseases
Read More
Pharmacopeia achieves milestone in GSK collaboration
Read More
SEC declares effective Valentis and Urigen merger
Read More
ViroPharma makes progress in phase II clinical program for HCV-796
Read More
New therapeutic agents for sleep disorders, depression and schizophrenia reported in recent patents
Read More
Sciele Pharma acquires Alliant Pharmaceuticals
Read More
Axcan initiates phase III trial of MAX-002 for ulcerative proctitis
Read More
Barrier reports results from phase II/III liarozole trial
Read More
Urigen assigns collaborative consultant for URG-301 program
Read More
Pluristem's PLX cells show potential for Parkinson's disease
Read More
Intermezzo effective in treating middle of the night awakening
Read More
Y-320: novel antiarthritic drug profiled at Mitsubishi Pharma
Read More
CAT-3888 shows activity in phase I and II trials in leukemia patients
Read More
A phase I study of SSR-244738 in patients with refractory solid tumors
Read More
Japanese launch for once-weekly Benet
Read More
Encouraging results with targeted radiotherapy in advanced lung cancer patients
Read More
Ceftobiprole submitted for cSSTI in E.U.
Read More
Third approvable letter for Thelin
Read More
FDA approval for Letairis for PAH
Read More
Inovelon launched in Germany for Lennox-Gastaut syndrome
Read More